Premium
The Association of British Clinical Diabetologists nationwide exenatide and liraglutide audits suggest a low incidence of acute pancreatitis. Response to Robson. Incretins and pancreatitis—what happens next? A personal viewpoint
Author(s) -
Ryder R. E. J.,
Sen Gupta P.,
Thong K. Y.
Publication year - 2013
Publication title -
diabetic medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.474
H-Index - 145
eISSN - 1464-5491
pISSN - 0742-3071
DOI - 10.1111/dme.12336
Subject(s) - liraglutide , exenatide , medicine , audit , diabetes mellitus , acute pancreatitis , incidence (geometry) , type 2 diabetes , endocrinology , management , economics , physics , optics